SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-303900
Filing Date
2022-12-13
Accepted
2022-12-13 17:11:03
Documents
13
Period of Report
2022-12-09
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d424180d8k.htm   iXBRL 8-K 28024
2 EX-3.1 d424180dex31.htm EX-3.1 135587
  Complete submission text file 0001193125-22-303900.txt   318226

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA srpt-20221209.xsd EX-101.SCH 2851
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20221209_lab.xml EX-101.LAB 17981
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20221209_pre.xml EX-101.PRE 11259
7 EXTRACTED XBRL INSTANCE DOCUMENT d424180d8k_htm.xml XML 3437
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 221460410
SIC: 2834 Pharmaceutical Preparations